The Enterprise Value as of November 2024 (TTM) for Dominari Holdings Inc. (DOMH) is 8.04M

According to Dominari Holdings Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.04M. This represents a change of -38.88% compared to the average of 13.16M of the last 4 quarters.

Dominari Holdings Inc. (DOMH) Historical Enterprise Value (quarterly & annually)

How has DOMH Enterprise Value performed in the past?

The mean historical Enterprise Value of Dominari Holdings Inc. over the last ten years is 4.52M. The current 8.04M Enterprise Value has changed 17.69% with respect to the historical average. Over the past ten years (40 quarters), DOMH's Enterprise Value was at its highest in in the June 2021 quarter at 78.29M. The Enterprise Value was at its lowest in in the December 2022 quarter at -15955980.88.

Dominari Holdings Inc. (DOMH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Dominari Holdings Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dominari Holdings Inc. (DOMH) Average Enterprise Value

How has DOMH Enterprise Value performed in the past?

The current Enterprise Value of Dominari Holdings Inc. (DOMH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Dominari Holdings Inc. (DOMH) Enterprise Value vs. Peers

How is DOMH’s Enterprise Value compared to its peers?

Dominari Holdings Inc.’s Enterprise Value is less than CytomX Therapeutics, Inc. (47.40M), less than Instil Bio, Inc. (258.54M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Spero Therapeutics, Inc. (11.13M), less than Assembly Biosciences, Inc. (90.29M), greater than Achilles Therapeutics plc (-48532901.00), less than NextCure, Inc. (21.96M), less than Senti Biosciences, Inc. (30.14M), greater than Hillstream BioPharma, Inc. (1.48M), less than SAB Biotherapeutics, Inc. (25.39M), greater than Quoin Pharmaceuticals, Ltd. (3.24M), less than Bolt Biotherapeutics, Inc. (38.25M), greater than Pasithea Therapeutics Corp. (-4187996.00), less than MediciNova, Inc. (38.55M), greater than Fresh Tracks Therapeutics, Inc. (-6447751.00),

Build a custom stock screener for Dominari Holdings Inc. (DOMH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dominari Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dominari Holdings Inc. (DOMH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dominari Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.